Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesRivaroxaban: An Oral Direct Factor Xa Inhibitor for the Prevention of Thromboembolism
Cardiology In Review, 06/19/09
Chen T et al. - Rivaroxaban is a novel oral direct factor Xa inhibitor. Rivaroxaban has been shown to have tolerable adverse effects and a low potential for drug-drug or drug-food interactions. It has the major advantages of once daily oral dosing and no required laboratory monitoring, giving it the potential to replace current antithrombotics in the market today.
Related Articles
A Cost-Effectiveness Model Comparing Rivaroxaban and Dabigatran Etexilate with Enoxaparin Sodium as Thromboprophylaxis after Total Hip and Total Knee Replacement in the Irish Healthcare Setting
PharmacoEconomics, 10/12/09
Relevance Score: 89%
The new oral anticoagulants
Blood, 11/13/09
Relevance Score: 80%
Today in CV/Thromboembolic...keeping you current
Receive free subspecialty "5-minute updates" via email
Graded contrast echocardiography in pulmonary arteriovenous malformations
European Respiratory Journal , 12/16/09
Pulmonary vein stenosis: Case report and literature review
Canadian Respiratory Journal, 12/16/09
Carotid body and cardiorespiratory alterations in intermittent hypoxia: the oxidative link
European Respiratory Journal , 12/15/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Community-acquired upper respiratory tract infections and the role of third-generation oral cephalosporins
Expert Review of Anti-infective Therapy, 12/17/09
Oral Immunotherapy with inactivated NTHi reduces severity of acute exacerbations in severe COPD
Chest, 12/16/09
Use of oseltamivir in children
Canadian Family Physician, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor